Watchlist Price Alert

Karyopharm Therapeutics I... (KPTI)

NASDAQ: KPTI · Real-Time Price · USD

4.54

0.00 (0.00%)

At close: Jun 17, 2025, 10:14 AM

Karyopharm Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-76.42M	-143.1M	-165.29M	-124.09M	-196.27M	-199.59M	-178.41M	-128.98M	-109.58M
Depreciation & Amortization	-2.16M	530K	621K	789K	972K	974K	735K	713K	717K
Stock-Based Compensation	18.43M	21.71M	35.4M	29.78M	24.41M	15.29M	17.27M	20.41M	22.28M
Other Working Capital	n/a	9.76M	-15.96M	-9.26M	5.54M	-1.8M	1.21M	32.05M	42K
Other Non-Cash Items	-69.53M	-3.28M	-294K	8.13M	8.4M	7.19M	1.42M	1.19M	1.2M
Deferred Income Tax	n/a	n/a	n/a	1.45M	904K	-1.38M	29K	n/a	n/a
Change in Working Capital	-302K	31.41M	-19.99M	-23.19M	1.36M	-13.31M	-169K	32.96M	987K
Operating Cash Flow	-127.49M	-92.72M	-149.55M	-107.12M	-160.23M	-190.82M	-159.12M	-73.72M	-84.39M
Capital Expenditures	-142K	n/a	-118K	-5.71M	-145K	-206K	-2.36M	-62K	-70K
Cash Acquisitions	n/a	n/a	104.26M	5.5M	53.54M	-78.66M	n/a	n/a	n/a
Purchase of Investments	-58.82M	-159.15M	-226.02M	-45.23M	-274.58M	-178.49M	-242.81M	-98.37M	-134.7M
Sales Maturities Of Investments	154.44M	167.09M	121.88M	192.78M	221.04M	257.14M	137.51M	115.54M	159.37M
Other Investing Acitivies	n/a	n/a	-104.26M	-5.5M	-53.54M	78.66M	-105.3M	17.17M	24.66M
Investing Cash Flow	95.47M	7.94M	-104.26M	141.84M	-53.69M	78.45M	-107.66M	17.11M	24.59M
Debt Repayment	83.3M	n/a	n/a	n/a	n/a	n/a	166.88M	n/a	n/a
Common Stock Repurchased	111M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-41.65M	1.12M	3.98M	63.74M	10.31M	78.11M	3.52M	858K	591K
Financial Cash Flow	41.65M	1.12M	193.74M	73.65M	172.08M	124.31M	316.11M	75.74M	51.16M
Net Cash Flow	9.62M	-83.69M	-60.56M	108.32M	-41.57M	11.95M	49.25M	19.33M	-8.7M
Free Cash Flow	-127.63M	-92.72M	-149.67M	-112.83M	-160.38M	-191.03M	-161.48M	-73.78M	-84.46M